InvestorsHub Logo
Followers 30
Posts 1939
Boards Moderated 0
Alias Born 01/11/2011

Re: Bngo post# 188137

Friday, 03/11/2016 11:45:17 AM

Friday, March 11, 2016 11:45:17 AM

Post# of 403278
Prioritizing abuse-deterrent formulations and overdose treatments: The FDA will encourage the development of more effective abuse-deterrent features and prioritize the issuance of guidance on generic opioid products in abuse-deterrent formulations.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News